Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Quidel Corp (QDEL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010876
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Quidel distributes its products through direct sales force and a network of national and regional distributors. It has a direct presence in the US and Germany. Quidel is headquartered in San Diego, California, the US.

Quidel Corp (QDEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quidel Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Quidel Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Quidel Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Quidel Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Quidel Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Quidel Corp, Medical Equipment, Deal Details 11
Asset Purchase 11
Quidel Acquires Triage and BNP Business from Alere 11
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 13
Partnerships 14
InGen BioSciences Enters Into Distribution Agreement With Quidel 14
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 15
Life Technologies Enters Into Co-Marketing Agreement With Quidel 16
Equity Offering 17
Quidel Completes Underwritten Public Offering Of US$60 Million 17
Debt Offering 19
Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 19
Acquisition 21
Quidel Acquires AnDiaTec, Molecular Diagnostics Company 21
Quidel Acquires BioHelix, Molecular Diagnostic Company, For US$10 Million 22
Quidel Corp – Key Competitors 23
Quidel Corp – Key Employees 24
Quidel Corp – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results 26
Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 28
Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 30
Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 31
Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 33
Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 34
Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results 35
Apr 27, 2016: Quidel Reports First Quarter 2016 Financial Results 37
Feb 17, 2016: Quidel Reports Fourth Quarter and Full Year 2015 Financial Results 39
Jan 07, 2016: Quidel Announces Preliminary Revenue for Fourth Quarter 2015 41
Product News 42
01/25/2016: Quidel Receives CE Mark for Its New Sofia Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis 42
Product Approvals 43
Jan 25, 2016: Quidel Receives CE Mark for Its New Sofia Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis 43
Other Significant Developments 44
Nov 27, 2017: Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets 44
Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Quidel Corp, Medical Equipment, Key Facts, 2016 2
Quidel Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Quidel Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Quidel Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Quidel Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Quidel Corp, Deals By Market, 2011 to YTD 2017 9
Quidel Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Quidel Acquires Triage and BNP Business from Alere 11
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 13
InGen BioSciences Enters Into Distribution Agreement With Quidel 14
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 15
Life Technologies Enters Into Co-Marketing Agreement With Quidel 16
Quidel Completes Underwritten Public Offering Of US$60 Million 17
Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 19
Quidel Acquires AnDiaTec, Molecular Diagnostics Company 21
Quidel Acquires BioHelix, Molecular Diagnostic Company, For US$10 Million 22
Quidel Corp, Key Competitors 23
Quidel Corp, Key Employees 24
Quidel Corp, Other Locations 25
Quidel Corp, Subsidiaries 25

★海外企業調査レポート[Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • H.B. Fuller Company:企業の戦略・SWOT・財務情報
    H.B. Fuller Company - Strategy, SWOT and Corporate Finance Report Summary H.B. Fuller Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Futuren (FTRN)-エネルギー分野:企業M&A・提携分析
    Summary Futuren, formerly Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The compa …
  • B&M European Value Retail S.A.:戦略・SWOT・企業財務分析
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • curasan AG (CUR):医療機器:M&Aディール及び事業提携情報
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • Ergon Energy Corporation Limited:企業の戦略・SWOT・財務分析
    Ergon Energy Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Ergon Energy Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ameresco Inc (AMRC):企業の財務・戦略的SWOT分析
    Ameresco Inc (AMRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a provider of instruments, reagents, and services for molecular profiling applications. The company's products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provid …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • VSTECS Holdings Ltd:企業の戦略・SWOT・財務情報
    VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kronos Worldwide Inc (KRO):企業の財務・戦略的SWOT分析
    Kronos Worldwide Inc (KRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurodyn Life Sciences Inc (Neurodyn Life Sciences), formerly Neurodyn Inc is a provider of validation and development of bioactives for neuroprotection and early treatment of neurological diseases. The company's products include neuroprotectant, memogain, progranulin, and nerve pain treatme …
  • Anadolu Hayat Emeklilik A.S.:企業の戦略・SWOT・財務情報
    Anadolu Hayat Emeklilik A.S. - Strategy, SWOT and Corporate Finance Report Summary Anadolu Hayat Emeklilik A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Anavex Life Sciences Corp (AVXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The c …
  • DePuy Synthes Inc:企業の製品パイプライン分析2018
    Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxi …
  • Genetic Signatures Ltd (GSS):企業の製品パイプライン分析
    Summary Genetic Signatures Ltd (Genetic Signatures) formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company. The company designs and manufactures real-time polymerase chain reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. It off …
  • Petroleos de Venezuela SA-石油・ガス分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆